- Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs
-
8-Aminoquinolines (8-AQs) are important class of anti-infective therapeutics. 5-Phenoxy 8-aminoquinoline analogs have shown improved metabolic stability compared to primaquine. In view or predictive role of monoamine oxidases (MAO) in metabolism of 8-amin
- Chaurasiya, Narayan D.,Ganesan, Shobana,Nanayakkara, N.P. Dhammika,Dias, Luiza R.S.,Walker, Larry A.,Tekwani, Babu L.
-
scheme or table
p. 1701 - 1704
(2012/04/04)
-
- Synthesis and anti-breast cancer activities of substituted quinolines
-
Promising anti-breast cancer agents derived from substituted quinolines were discovered. The quinolines were readily synthesized in a large scale from a sequence of reactions starting from 4-acetamidoanisole. The Michael addition product was isolated as the reaction intermediate in the ring closing reaction of 4-amino-5-nitro-2-(3-trifluoromethylphenyloxy)anisole with methyl vinyl ketone leading to 6-methoxy-4-methyl-8-nitro-5-(3-trifluoromethylphenyloxy)quinoline (14). The amino function of 8-amino-6-methoxy-4-methyl-5-(3-trifluoromethylphenyloxy)quinoline, prepared from 14, was connected to various side chains via alkylation with N-(3-iodopropyl)phthalimide, Michael addition with acrylonitrile, and reductive amination with various heterocycle carboxaldehydes, such as imidazole-4-carboxaldehyde, thiophene-2-carboxaldehyde, and 2-furaldehyde. Effects of the substituted quinolines on cell viability of T47D breast cancer cells using trypan blue exclusion assay were examined. The results showed that the IC50 value of 6-methoxy-8-[(2-furanylmethyl)amino]-4-methyl-5-(3-trifluoromethylphenyl oxy)quinoline is 16 ± 3 nM, the lowest IC50 out of all the quinolines tested. IC50 values of three other quinolines are in the nanomolar range, a desirable range for pharmacological testing.
- Shi, Aibin,Nguyen, Thu A.,Battina, Srinivas K.,Rana, Sandeep,Takemoto, Dolores J.,Chiang, Peter K.,Hua, Duy H.
-
supporting information; experimental part
p. 3364 - 3368
(2009/04/11)
-
- COMPOUNDS AFFECTING GAP JUNCTION ACTIVITY
-
ThThis invention relates to novel quinoline compounds which affect gap junction activity. Also provided are methods of using such compounds and compositions containing the compounds to treat gap junction disorders.
- -
-
-